Inflammation Is More Sensitive than Cell Proliferation in Response to Rapamycin Treatment in Polycystic Kidney Disease
Introduction: It has been reported that rapamycin inhibited inflammation in renal interstitial diseases. We therefore hypothesized that rapamycin could attenuate inflammation in polycystic kidney disease (PKD). Methods: Han:SPRD rats were treated with rapamycin by daily gavage from 4 weeks to 12 wee...
Main Authors: | Ming Yang, Jiayi Lv, Chanjuan Gong, Cheng Xue, Lili Fu, Shunjie Chen, Changlin Mei |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2024-01-01
|
Series: | Kidney & Blood Pressure Research |
Subjects: | |
Online Access: | https://beta.karger.com/Article/FullText/535750 |
Similar Items
-
Mammalian target of rapamycin inhibition in polycystic kidney disease: From bench to bedside
by: Hyun-Jung Kim, et al.
Published: (2012-09-01) -
Short‐term rapamycin administration elevated testosterone levels and exacerbated reproductive disorder in dehydroepiandrosterone‐induced polycystic ovary syndrome mice
by: Zaixin Guo, et al.
Published: (2021-05-01) -
Low Concentration of Rapamycin Inhibits Hemangioma Endothelial Cell Proliferation, Migration, and Vascular Tumor Formation in Mice
by: Ningning Zheng, PhD, et al.
Published: (2014-12-01) -
Functional Characterization of Target of Rapamycin Signaling in Verticillium dahliae
by: Linxuan Li, et al.
Published: (2019-03-01) -
Outcome of Rapamycin Therapy for PostTransplant- Lymphoproliferative Disorder after Kidney Transplantation: Case Series
by: Farzaneh Ashrafi, et al.
Published: (2015-03-01)